Trial NC-HEM-07-2

A Phase III, Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of GAMMAPLEX in Chronic Idiopathic Thrombocytopenic Purpura (ITP)

Type: Non-Cancer Related; Non- Therapeutic
Phase: Phase III
Status: Open to Accrual
Treatments: Immunotherapy
Randomized: No
Defintions of terms and FAQ about clinical trials.

Trial Leaders/Researchers: Howard Liebman, M.D.
Other Trial Staff: Brad Hutchinson, R.N., Melissa Peralta, D.M.

Staff may log in to see study documents.

For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or clinical.trials@med.usc.edu.

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3111.